DLA
Douglas Lane & Associates’s Organon & Co OGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Buy |
315,952
+50,393
| +19% | +$488K | 0.04% | 135 |
|
|
2025
Q1 | $3.95M | Sell |
265,559
-5,279
| -2% | -$78.6K | 0.06% | 134 |
|
|
2024
Q4 | $4.04M | Sell |
270,838
-260,842
| -49% | -$3.89M | 0.06% | 133 |
|
|
2024
Q3 | $10.2M | Buy |
531,680
+3,792
| +0.7% | +$72.5K | 0.14% | 118 |
|
|
2024
Q2 | $10.9M | Buy |
527,888
+39,584
| +8% | +$819K | 0.16% | 111 |
|
|
2024
Q1 | $9.18M | Buy |
488,304
+127,529
| +35% | +$2.4M | 0.13% | 119 |
|
|
2023
Q4 | $5.2M | Sell |
360,775
-276,056
| -43% | -$3.98M | 0.08% | 125 |
|
|
2023
Q3 | $11.1M | Buy |
636,831
+85,218
| +15% | +$1.48M | 0.19% | 110 |
|
|
2023
Q2 | $11.5M | Buy |
551,613
+85,846
| +18% | +$1.79M | 0.19% | 107 |
|
|
2023
Q1 | $11M | Sell |
465,767
-958
| -0.2% | -$22.5K | 0.18% | 110 |
|
|
2022
Q4 | $13M | Buy |
466,725
+236,093
| +102% | +$6.59M | 0.22% | 107 |
|
|
2022
Q3 | $5.4M | Buy |
230,632
+29,893
| +15% | +$700K | 0.1% | 116 |
|
|
2022
Q2 | $6.78M | Sell |
200,739
-3,085
| -2% | -$104K | 0.12% | 114 |
|
|
2022
Q1 | $7.12M | Buy |
203,824
+26,298
| +15% | +$919K | 0.1% | 114 |
|
|
2021
Q4 | $5.41M | Buy |
177,526
+59,165
| +50% | +$1.8M | 0.07% | 117 |
|
|
2021
Q3 | $3.88M | Buy |
118,361
+63,249
| +115% | +$2.07M | 0.06% | 123 |
|
|
2021
Q2 | $1.67M | Buy |
+55,112
| New | +$1.67M | 0.02% | 140 |
|